1. Home
  2. HBIO vs NEPH Comparison

HBIO vs NEPH Comparison

Compare HBIO & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBIO
  • NEPH
  • Stock Information
  • Founded
  • HBIO 1901
  • NEPH 1997
  • Country
  • HBIO United States
  • NEPH United States
  • Employees
  • HBIO N/A
  • NEPH N/A
  • Industry
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • NEPH Medical/Dental Instruments
  • Sector
  • HBIO Industrials
  • NEPH Health Care
  • Exchange
  • HBIO Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • HBIO 16.9M
  • NEPH 16.8M
  • IPO Year
  • HBIO 2000
  • NEPH 2004
  • Fundamental
  • Price
  • HBIO $0.40
  • NEPH $1.86
  • Analyst Decision
  • HBIO Buy
  • NEPH Buy
  • Analyst Count
  • HBIO 2
  • NEPH 1
  • Target Price
  • HBIO $4.50
  • NEPH $5.00
  • AVG Volume (30 Days)
  • HBIO 349.2K
  • NEPH 12.1K
  • Earning Date
  • HBIO 05-06-2025
  • NEPH 05-08-2025
  • Dividend Yield
  • HBIO N/A
  • NEPH N/A
  • EPS Growth
  • HBIO N/A
  • NEPH N/A
  • EPS
  • HBIO N/A
  • NEPH 0.01
  • Revenue
  • HBIO $94,135,000.00
  • NEPH $14,162,000.00
  • Revenue This Year
  • HBIO N/A
  • NEPH $9.23
  • Revenue Next Year
  • HBIO $8.58
  • NEPH $12.99
  • P/E Ratio
  • HBIO N/A
  • NEPH $277.38
  • Revenue Growth
  • HBIO N/A
  • NEPH N/A
  • 52 Week Low
  • HBIO $0.36
  • NEPH $1.36
  • 52 Week High
  • HBIO $4.08
  • NEPH $2.55
  • Technical
  • Relative Strength Index (RSI)
  • HBIO 35.65
  • NEPH 51.99
  • Support Level
  • HBIO $0.56
  • NEPH $1.66
  • Resistance Level
  • HBIO $0.45
  • NEPH $2.05
  • Average True Range (ATR)
  • HBIO 0.06
  • NEPH 0.11
  • MACD
  • HBIO 0.02
  • NEPH -0.01
  • Stochastic Oscillator
  • HBIO 28.71
  • NEPH 35.71

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

Share on Social Networks: